30 Day Rehospitalization Risk in Hemodialysis Patients

Re-hospitalization Hemodialysis Clinical Trial

Official title:

A Randomized Controlled Trial of a Checklist Intervention to Reduce 30 Day Rehospitalization Risk in Hemodialysis Patients

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02553564
• Other study ID #: Nephrology - 06032015
• Status: Terminated
• Phase: N/A
• First received: September 15, 2015
• Last updated: March 29, 2018
• Start date: November 22, 2017
• Est. completion date: March 15, 2018

Study information

• Verified date: March 2018
• Source: Northwell Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

After a hospitalization, dialysis patients have a high risk of being admitted to the hospital again within 30 days. The purpose of this research study is to test a new way of reducing the chance of patients being hospitalized again. In this study investigator will evaluate a checklist driven evaluation upon return to the dialysis facility as a method to reduce the rate of rehospitalizations in hemodialysis patients.

Description:

There are an excessive number of 30 day readmissions after hospital discharges of dialysis patients in the U.S. (35.2%). Investigators recent research has found that approximately 2/3 of these readmissions are potentially avoidable. Investigators believe that among the causes for the excessive number of readmissions, the most important may be that patients usually do not receive a clinical assessment upon return to dialysis after a hospitalization. An all too common practice in the U.S. is for the nephrologist to not see the patient but to give verbal orders to the dialysis nurse to resume previous orders. This increases readmission risk in that there are a number of key clinical processes that if completed on return to dialysis might greatly reduce rehospitalization risk. Nephrologists are often not available to see patients in the peri-discharge period, but there is a trend towards an increasing number of U.S. dialysis facilities now having nurse practitioners (NP) working in the units. Investigators believe that NPs using a checklist can conduct a post-discharge clinical encounter that would allow for key care processes to be carried out and to direct telephone communication with the treating nephrologist. Our objective is to reduce the risk of dialysis patient readmissions within 30 days through the use of this intervention. Our research question is whether this intervention would be effective for reducing 30 day readmission risk. Our hypothesis is that the intervention will prove to be more effective then usual care for reducing 30 day readmission risk.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 3
• Est. completion date: March 15, 2018
• Est. primary completion date: March 15, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older

• Must have been an existing patients of the outpatient dialysis units for at least 1 month prior to the index hospitalization

• Index hospitalization must be from an acute care hospital

Exclusion Criteria:

• Hospital discharges against medical advice

• Assessment cannot be initiated within 96 hours of hospital discharge

• Primary hospital diagnosis related to cancer, renal transplant, mental health or rehabilitation

• Hospital admission was the 5th or more in the previous 12 months

• Failure to provide informed consent

Related Conditions & MeSH terms

• Re-hospitalization Hemodialysis

Intervention

Other:
• Checklist driven clinical encounter after hospital discharge
Within 96 hours of hospital discharge an Nurse Practitioner will perform a checklist guided assessment to preventing rehospitalizations. The assessment consists of the following: The participants's hospital course will be reviewed and their clinical recovery and stability assessed. Determination of the participants's estimated dry weight (EDW). The participants's post discharge medications will be checked, compared to the prehospitalization medication, and discrepancies will be reviewed and corrected. Blood tests will be ordered for the participants's first return dialysis treatment if medically appropriate after clinical assessment. Write new dialysis orders. Dialysis Access- review access and determine any changes required in treatment

Locations

Country	Name	City	State
United States	LIJ satellite dialysis unit	Queens Village	New York

Sponsors (1)

Lead Sponsor	Collaborator
Northwell Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rehospitalization rate	Percentage of patients in each group requiring readmission to an acute care hospital within 30 days of discharge after an acute care hospitalization.	Up to 5 weeks
Secondary	Cause of readmissions	Percentage of rehospitalizations per group for volume overload, infection or vascular access complications	Up to 5 weeks
Secondary	Days to readmission	Number of days to readmission	Up to 5 weeks
Secondary	Average time in minutes required to perform the intervention		Up to 5 weeks